HOME ABOUT US TECHNOLOGY PRODUCTS CONTACT US  
 
       
 
 

News
   
  About Us
  Career Opportunities
  Directions
  News
     


March 16, 2005
BioHelix Corporation was awarded two NIH grants to develop new HDA technologies.

BioHelix announced today that it was awarded two independent Small Business Innovative Research (SBIR) grants from the National Institutes of Health.  One of the grants will support the development of a novel HDA technology that is under investigation.  The new HDA system allows isothermal amplification of target sequences at room temperature.  The second award funds the second phase of our ongoing research to develop an isothermal HDA system for long range targets.  Current HDA systems robustly amplify sequences of 200 bp in size; the long-range HDA platform being investigated will allow the amplification of targets of 2 – 3 kb in size.  The SBIR awards will enable BioHelix to continue developing innovative isothermal amplification tools for use in research and diagnostics. 
 
<<Back to News
         
Privacy, Limitation, Warranty, Disclaimer